We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Bonesupport Holding Ab | LSE:0RQO | London | Ordinary Share | SE0009858152 | BONESUPPORT HOLDING ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 12.12 | 2,063 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Surgical,med Instr,apparatus | 591.08M | 245.02M | 3.7013 | 8.85 | 802.32M |
From Dec 2019 to Dec 2024
LUND, Sweden, April 29, 2020 /PRNewswire/ -- BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries announces a change in its leadership team that will take place June 1, 2020. Michael Roth starts in the position as the company's General Manager & Executive Vice President Commercial Operations North America. Michael has more than 20 years of experience within the orthopedic sector with both direct and distributor-based sales management. Michael has a solid leadership experience from both sales and marketing and from small as well as large companies, amongst them Wright Medical Technology, Microport Orthopedics and Howmedica.
"Michael Roth is the leader we need on the American market in order to take BONESUPPORT to the next level. His experience together with his leadership and capability to develop high performing, dynamic teams will be a contributing factor to our continued success on the important US market and with the coming launch of CERAMENT G," said Emil Billbäck, CEO at BONESUPPORT.
For more information contact:
BONESUPPORT AB
Emil Billbäck, CEO
+46 (0) 46 286 53 70
Håkan Johansson, CFO
+46-(0)-46-286-53-70
ir@bonesupport.com
Cord Communications
Charlotte Stjerngren
+46-(0)-708-76-87-87
charlotte.stjerngren@cordcom.se
www.cordcom.se
About BONESUPPORT™
BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient's own bone and have the capability of eluting drugs. BONESUPPORT's bone graft substitutes are based on the patented technology platform CERAMENT. The Company is conducting several clinical studies to further demonstrate the clinical and health economic benefits that its products deliver and a Premarket approval filing with the FDA (USA) for CERAMENT G is planned in 2021. The Company is based in Lund, Sweden, and the net sales amounted to SEK 155 million in 2019. Please visit www.bonesupport.com for more information.
BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/bonesupport-holding-ab/r/bonesupport-appoints-michael-roth-as-general-manager---executive-vice-president-commercial-operation,c3100496
The following files are available for download:
https://mb.cision.com/Main/16090/3100496/1239002.pdf | Release |
View original content:http://www.prnewswire.com/news-releases/bonesupport-appoints-michael-roth-as-general-manager--executive-vice-president-commercial-operations-north-america-301049450.html
SOURCE Bonesupport Holding AB
Copyright 2020 PR Newswire
1 Year Bonesupport Holding Ab Chart |
1 Month Bonesupport Holding Ab Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
